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Adult germline stem cells (AGSCs) self-renew (Thy1+
enriched) or commit to gametogenesis (Kit+ en-
riched). To better understand how chromatin regu-
lates AGSC biology and gametogenesis, we derived
stage-specific high-resolution profiles of DNA
methylation, 5hmC, histone modifications/variants,
and RNA-seq in AGSCs and during spermatogen-
esis. First, we define striking signaling and transcrip-
tional differences between AGSC types, involving
key self-renewal and proliferation pathways. Sec-
ond, key pluripotency factors (e.g., Nanog) are silent
in AGSCs and bear particular chromatin/DNAme
attributes that may ‘‘poise’’ them for reactivation
after fertilization. Third, AGSCs display chromatin
‘‘poising/bivalency’’ of enhancers and promoters
for embryonic transcription factors. Remarkably,
gametogenesis occurs without significant changes
in DNAme and instead involves transcription of
DNA-methylated promoters bearing high RNAPol2,
H3K9ac, H3K4me3, low CG content, and (often)
5hmC. Furthermore, key findings were confirmed in
human sperm. Here, we reveal AGSC signaling asym-
metries and chromatin/DNAme strategies in AGSCs
to poise key transcription factors and to activate
DNA-methylated promoters during gametogenesis.
INTRODUCTION
Cellular epigenomes are complex, reflecting the cell’s current
transcriptional program, its developmental history, and the
‘‘poising’’ of genes for future expression. Viewed this way,
male adult germline stem cells (AGSCs) represent a particularly
interesting node in development. First, they are the final germline
stem cell, originating from primordial germ cells (PGCs). Second,
AGSCs sit at the beginning of a unipotent developmental
pathway involving meiosis and, subsequently, spermiogenesis.CA major question of AGSC biology is whether and how DNA
methylation (DNAme) and chromatin patterns play major roles
in AGSC identity, unipotency, self-renewal, and their preparation
for—and commitment to—spermatogenesis. Likewise, once
committed to spermatogenesis, do DNAme and chromatin
dynamics help guide the developmental stages while still retain-
ing competency for genome pluripotency after fertilization? This
work aims to address these questions through extensive DNAme
and chromatin profiling of AGSCs and key stages of spermato-
genesis in the mouse, and through comparisons to PGCs and
embryonic stem cells (ESCs).
Consideration of AGSCs is informed by studies on their
precursors: zygotes, inner cell mass (ICM)/ESCs, and PGCs.
Zygotes and PGCs are the two mammalian cell types that
undergo extensive genomewide changes in their epigenomes,
termed ‘‘reprogramming’’ (Guibert et al., 2012; Hajkova et al.,
2008; Reik et al., 2001; Sasaki and Matsui, 2008; Smith et al.,
2012). Following fertilization, the paternal genome undergoes
chromatin repackaging, and both the paternal and maternal
genomes experience active and passive lowering of DNAme
(Guibert et al., 2012; Hajkova et al., 2008; Reik et al., 2001;
Sasaki and Matsui, 2008; Smith et al., 2012). The second phase
of reprogramming occurs in PGCs during their migration and
early residence within the gonad, and it involves nearly complete
removal of DNAme, including the erasure of parental DNAme
imprints (Dawlaty et al., 2011; Hackett et al., 2012, 2013; Seisen-
berger et al., 2012; Seki et al., 2005). Following this phase,
DNAme levels in PGCs/gonocytes are slowly restored (em-
bryonic day [E]13.5–E16.5), and sex-specific imprints are
established in themale gonocytes prior to birth, generating sper-
matogonial stem cells (SSCs) in the neonate and AGSCs in the
adult. Here, we provide a genomic understanding of two key
AGSC states: the self-renewing and transplantable state
(Thy1+) versus the state committed to gametogenesis (Kit+).
We also provide an in-depth genomic examination of sper-
matogenesis. SSCs/AGSCs either self-renew to form two single
unpaired cells (As) or instead form a paired cell connected by
an intracellular bridge (Apr), from which subsequent divisions
give rise to aligned chains of Aal andB spermatogonia committed
to meiosis. Meiosis then creates tetraploid primary sper-
matocytes, diploid secondary spermatocytes, haploid roundell Stem Cell 15, 239–253, August 7, 2014 ª2014 Elsevier Inc. 239
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Epigenomic Maps of Germline Stem Cellsspermatids, and, ultimately, spermatozoa (Hess and Renato de
Franca, 2008). These transitions have been characterized by
global changes in chromatin (Delaval et al., 2007; Khalil et al.,
2004; Oakes et al., 2007; Soumillon et al., 2013; Turner, 2007).
However the gene-specific locations of these modifications
and their relationships to DNAme and transcription have largely
not been characterized at a genomewide scale.
Interestingly, in humans and mice, mature germ cells retain
nucleosomes (often modified at H3K4me3 and H3K27me3) at
the promoters of hundreds of genes of developmental impor-
tance in the embryo, including Hox-, Fox-, Sox- and Gata-family
genes, particular microRNAs (miRNAs), and long-noncoding
RNAs (Brykczynska et al., 2010; Hammoud et al., 2009). The
coincidence of H3K4me3 (correlated with gene activation) with
H3K27me3 (correlated with silencing) is termed ‘‘bivalency’’—a
chromatin property discovered at developmental genes in
ESCs that underlies gene poising (Bernstein et al., 2006).
Notably, these bivalent promoters are almost invariably DNA
hypomethylated in both ESCs and sperm. Recently, bivalent
nucleosomes have been localized at developmental genes in
spermatocytes and spermatids in mice (Erkek et al., 2013; Lesch
et al., 2013), and also at E16.5 PGCs (Ng et al., 2013), but AGSCs
have not been tested. Here, our work uses extensive transcrip-
tome and chromatin profiling to address several outstanding
issues, including: (1) the transcriptome and chromatin/DNA
differences between self-renewing versus committed/differenti-
ating AGSCs, (2) whether bivalency and DNA hypomethylation
resides at genes for embryo development in AGSCs, (3) whether
key genes for pluripotency (e.g., Nanog and Sox2) are bivalent/
poised in AGSCs, and (4) how chromatin and DNAme are used
to regulate genes during germline development.
RESULTS
Genomic Profiling of Thy1+ or Kit+ AGSCs and Staged
Spermatogenesis in Mice
Thy1+/Kit AGSCs are self-renewing and transplantable,
whereas Thy1/Kit+ cells are poorly transplantable and largely
committed to gametogenesis (Oatley et al., 2009). Here, we iso-
lated these two populations from the adult (8 weeks, detailed
later). In addition, we isolated cells from the three main stages
of gametogenesis: spermatocytes, spermatids, and mature
sperm (Figure 1A; for all isolations and purity/validation, see Fig-
ure S1A available online). Below, we provide extensive profiling
of these cell types. DNAme analyses involved whole-genome
‘‘shotgun’’ bisulfite sequencing (conversion efficiency > 99%)
and typically >303 genome coverage (Table S1A). For compar-
isons, we reprocessed data from ESCs and PGCs (Seisenberger
et al., 2012; Stadler et al., 2011). Our 5hmC and histone modifi-
cation data sets in germ cells were compared to prior ESCs and/
or PGC data sets (Mikkelsen et al., 2007; Ng et al., 2013). Tran-
scriptional profiling of long and various small RNAs involved
strand-specific RNA sequencing (RNA-seq).
Thy1+ and Kit+ AGSCs Display Distinctive Gene
Expression Signatures
We first examined the known molecular signatures/markers
that distinguish Thy1+ versus Kit+ AGSCs, using stringent criteria
(p < 0.05 and is greater than or equal to 4-fold change). First, we240 Cell Stem Cell 15, 239–253, August 7, 2014 ª2014 Elsevier Inc.find Thy1 or Kit selectively expressed, in alignment with our
enrichment goals (Figures 1B and 1C). In Thy1+ cells, we find col-
ony-stimulating factor 1 receptor (Csf1r) and integrin B2 (Itgb2)
specifically expressed (Oatley et al., 2009) and Gfra1 (the recep-
tor for the GDNF ligand) expressed at somewhat higher relative
levels—a pathway of known importance for AGSC self renewal
in neonates. In Kit+ cells, Stra8 and multiple aldehyde dehydro-
genases (e.g., Aldh2) are specifically expressed, consistent
with known roles for retinoic acid in committing Kit+ cells to
meiosis (Figures 1B, 1C, and S1B). Notably, Aldh2, Stra8, and
Spo11 are the only promoters that lose H3K27me3 (Figure S1B;
data not shown), suggesting their bivalent-to-active chromatin
transition. Thus, our data sets verify the known distinctive differ-
ences between Thy1+ and Kit+ cells and reveal very rare in-
stances of bivalency resolution in germline development.
Thy1+ and Kit+ AGSCs Display Distinctive Signaling
Pathways and Chromatin Transitions
We then identified factors with strong expression selectively in
Thy1+ versus Kit+ cells. Notably, Thy1+ cells selectively upregu-
late particular receptors (Fgfr1 and Tnfr), cell cycle regulators
(Ccne1), proto-oncogenes (Fyn and Lyn), growth factors (Tgfb,
Gdf15, and Pdgf), and tumor suppressors (Dab2 and Aim2) (Fig-
ures 1B and 1C). Likewise, we find many signaling factors/path-
ways specifically expressed/upregulated in Kit+ cells, including
multiple receptors (Egfr, Fgfr2, Lifr, Pdgfra, Esr) and several
nuclear hormone orphan receptors, signaling factors (Bmp4),
and cell cycle factors (Ccnd2) (Figures 1B and 1C; data not
shown). Notably, several JNK pathway target genes (Atf, Jun,
p53, and Rac) are markedly upregulated in Kit+ AGSCs
(compared to Thy1+), consistent with their proliferative state. It
is interesting that we found H-Ras pathway components highly
expressed in both AGSC types. Furthermore, several key tran-
scription factors are expressed specifically in Kit+ cells, including
c-Myc, Fos, and Solhlh1/2. Here, roles forSolhlh1/2 in promoting
spermatogonial differentiation and meiosis are known (Ballow
et al., 2006; Hao et al., 2008), whereas functional roles for
c-Myc or Fos remain to be explored. Taken together, our data
sets should prove highly useful in optimizing cell markers for
transplantation studies, for studying signaling within the testic-
ular niche, and in revealing new factors that may promote
AGSC renewal or differentiation (Figure 1D).
Rare DNAme Differences between Thy1+ and Kit+
AGSCs
We find global DNAme patterns of Thy1+ and Kit+ AGSCs
remarkably similar (r = 0.96; Figure 1E; Figure S1C) and differ-
ences at promoters extremely rare; only seven promoters exhibit
>30% change in fraction DNAme: Syce3, Tex12, Hormad1
(important for meiosis), Ankrd7, and Ccin lose DNAme, whereas
Kcng4 and Kcnmb2 (potassium channels) gain DNAme. How-
ever, moderate increases in both bulk and promoter DNAme
levels are observed on transitioning to the Kit+ stage (Figures
2A and 2B, clusters 1 and 4; Table S1A [note: PGCs/gonocytes
are recovering from genomewide reprogramming]) but are pro-
portional to the slight increase in genome average DNAme rather
than a conversion from unmethylated to methylated. Thus, the
transition between self-renewal and commitment to gametogen-
esis does not generally involve changes in promoter DNAme.
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Figure 1. Expression of Key Stem Cell and Self-Renewal Factors Differ between Thy1+ and Kit+ AGSCs
(A) Graphical summary of data sets generated (gray boxes). S’cytes, spermatocytes; S’tids, spermatids.
(B) MA plot of Thy1+/Kit+ expression data sets. Red dots indicate p < 0.05.
(C) Transcriptional dynamics of stem cell factors in ESCs and germ cells. Browser snapshots of Itgb1/2,Myc, Klf4,Csf1r, Thy1, Kit, Lifr, Tgfb1, Aim2,Gdf15, Egfr,
and Pdgfra. y axis: RNA-seq (FPKM). Note: mouse ESC (mESC) RNA-seq data are from Klattenhoff et al. (2013); PGC E16.5 RNA-seq data are from Seisenberger
et al. (2012).
(D) Graphical summary of genes and pathways differentially expressed between Thy1+ and Kit+ cells.
(E) Scatterplots comparing DNAme (fraction CG methylation) at promoters (TSS ± 2 kb) in Thy1+ versus Kit+.
See also Figure S1 and Tables S1A–S1C and S1F.
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Figure 2. DNAme and Chromatin Dynamics
between Germ Stem Cells and ESCs
(A) Class average maps of DNAme (x axis, TSS ±
5 kb; y axis, fraction CG methylation) for all cell
types.
(B) K-means clustering (n = 4) of DNAme (mean
fraction CG methylation) at TSS regions (±2 kb).
ESC DNAme data set from Stadler et al. (2011);
E16.5 from Seisenberger et al. (2012).
(C) A snapshot of theHoxd cluster and neighboring
genes, depicting DNAme (mean fraction CG
methylation), CGIs, and H3K4me3 or H3K27me3
(q value [Qval] FDR) across all cell types.
(D) K-means clustering of active and repressive
histone modifications at all TSS (±2 kb), with
enriched GO terms in the middle panel and
DNAme class average plots on the right. Dev.,
developmental.
(E) Average promoter DNAme of meiotic and DNA
repair genes in ESCs, PGCs, and AGSCs.
(F) Boxplots representing the average H3K4me3 or
H3K27me3 levels at meiotic and DNA repair
genes.
(G) RNA-seq heatmap (Z score) for selected
meiotic genes (note: peak expression of Sycp,
Spata22, and Spo11 is in spermatocytes; data not
shown).
(H) PCA plot depicting transcriptome relationships
between ESCs, AGSCs, and PGCs.
See also Figure S1 and Tables S2A–S2C.
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Bivalency of Developmental Genes
Next, we compared chromatin/DNAme patterns of germline and
ESCs. At promoters, DNAme profiles of ESCs, E16.5 PGCs, and
AGSCs (Thy1+ and Kit+) are highly similar (r > 0.85 for all pairwise
comparisons; Figure S1C); evident at promoter (class average)
maps of DNAme (Figure 2A), promoter clustering (Figure 2B,
clusters 1 and 2), and when viewing DNAme along the physical
map (HoxD locus; Figure 2C). As expected, DNA hypomethyla-
tion aligns with CpG island strength (Figure 2C; Table S1B).
Notably, both Thy1+ and Kit+ AGSCs display regions of ‘‘biva-
lent’’ chromatin with underlying DNA hypomethylation, which
localized to the promoters of most transcription factors utilized
during embryo development, including Hox-, Fox-, Sox-, Tbx-,
and Gata-family transcription factors (e.g., HoxD locus; Figures
2C and 2D, cluster 1; Table S2A), but not other gene classes
(e.g., housekeeping genes, Figure 2D, cluster 4; Table S2B)—
properties shared with PGCs and ESCs (Farthing et al., 2008).
It is interesting that, when considering bivalent genes, we found
a 90% or 70% overlap when comparing ESCs to AGSCs or
AGSCs to PGCs, respectively (p < 0.01). However, AGSCs
have many more bivalent genes than ESCs, including zinc finger
clusters, protocadherins, Wnt pathway, germline specification,242 Cell Stem Cell 15, 239–253, August 7, 2014 ª2014 Elsevier Inc.PRDM family, toll-like receptors, and
solute carrier genes. Finally, develop-
mental transcription factors display
relatively wide promoter and gene DNA
hypomethylation (Figure 2D [compare
clusters 1 and 4, right panel]). Thus, key
genes for embryo development are selec-tively packaged/poised in large regions of bivalent chromatin
with accompanying DNA hypomethylation in the germline cycle.
DNAme Profiles of AGSCs and ESCs Differ at Key Loci
for Germline Development
Although DNAme is similar overall, comparison of AGSCs (either
Thy1+ or Kit+) to ESCs yield 330 differentially methylated
promoters (with >30% change in fractionmethylation; Figure 2B,
cluster 3; Table S1C). Genes DNA methylated in ESCs, but de-
methylated in Thy1+ and Kit+ AGSCs included Dppa3, Stra8,
Piwil, Mov10, Scp-family, Tex-family, Rnf7, Sohlh, Tdrd1,
Catsper-family, Nobox, Adad, and Spag – and GO analyses en-
riched gene categories of germline reproductive development
(meiosis, Piwi-interacting RNAs [piRNAs], chromatoid bodies),
consistent with silencing of these genes in ESC and their utiliza-
tion in AGSC (Table S1C). Conversely, genes specifically meth-
ylated in AGSCs included particular small nucleolar RNAs
[snoRNAs], and notably, key genes involved in ESC self-renewal.
AGSCs and PGCs Differ at Genes for Olfactory
Receptors, Proliferation, and Meiosis
We observed 150 gene promoters that acquire methylation
between E16.5 PGCs/gonocytes and Kit+ AGSCs (Figure 2B,
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Figure 3. AGSCs and ESCs Differ in Chromatin Packaging and Utilization of Pluripotency Factors
(A) Browser snapshots depicting genomic features of key pluripotency genes (Oct4, Nanog, Sox2, Prdm14, Klf4) in mouse ESC (mESC) and stages of sper-
matogenesis. A black bar denotes promoter regions, and a gold bar denotes the enhancer regions. S’Cytes, spermatocytes; S’Tids, spermatids.
(B) Same as in (A) for the self-renewal factor Lefty.
(C) Summary schematic for key pluripotency factors in ESCs, PGCs (E16.5), and AGSCs.
(D) Class average maps of DNAme (fraction CG methylation) across binding site regions (±2.5 kb) for pluripotency factors determined in ESCs.
See also Figure S3 and Tables S1D, S1E, and S3A–S3E.
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Epigenomic Maps of Germline Stem Cellscluster 4; Table S1C). Notably, the majority (90) are olfactory
receptors, which may be needed for PGC homing/migration to
the gonad but are silenced after residence is established. The
remainder include genes linked to cell proliferation or metastasis
(i.e., Cecams, Prl), proinflammatory cytokines (Il23, Ifi27l2a, Irf7),
and three miRNAs (miR-1187, miR-467b, and miR-483) with
roles in apoptosis, angiogenesis, and cancer, respectively.
Notably, we found the promoters of many key meiosis-spe-
cific/promoting genes (e.g., Stra8, Tex11/14/15/19/40, Spo11,
Spata22, Sycp1/2/3, DMRTc2) partially DNA methylated in
E16.5 PGCs (comparable to the PGC genome average) but fully
hypomethylated in both AGSC populations (Figures 2E and S1B;
and data not shown). Curiously, meiotic gene promoters in Thy1+
cells are marked with H3K4me3, but not transcribed, and lack
H3K27me3—suggesting alternative modes of repression (Fig-
ures 2F and 2G). Thus, between E16.5 and AGSCs, many keyCgenes for meiosis lose DNAme (likely to prepare for activation
during spermatogenesis), whereas key genes linked to prolifera-
tion or cell migration become methylated and silenced.
AGSCs, PGCs at E16.5, and ESCs Differ in Stem/Germ
Cell Markers and Pluripotency Factor Utilization
Principal-component analysis of RNA profiling reveals similarity
between AGSC types but striking differences between AGSCs
and ESCs or PGCs (Figure 2H), especially regarding pluripo-
tency. Notably, AGSCs express high Klf4 and low Oct4, but in
contrast to ESCs, AGSCs entirely lack expression of Nanog,
Sox2, Lefty, and Prdm14 (Figure 3A), extending on recent data
from E16.5 PGCs/gonocytes (Seisenberger et al., 2012). Further-
more, AGSCs share additional factors expressed in ESCs (Klf2,
Etv5, Pin1, Aldh2, Myc, Msh, and Rex1) (Figure S2A). Although
AGSCs lack certain self-renewal factors present in ESCs, theyell Stem Cell 15, 239–253, August 7, 2014 ª2014 Elsevier Inc. 243
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Epigenomic Maps of Germline Stem Cellsexpress additional factors (absent in ESCs) of known importance
in the self-renewal of adult stem cells (e.g., Bmi1, Lrig1; Fig-
ure S2A) or neonatal SSCs (e.g., Plzf,Dazl, Taf4b, andGfra1; Fig-
ure S2A; data not shown). Taken together, AGSCs utilize a very
different self-renewal network than ESCs. Furthermore, certain
factors of known importance in neonatal SSC self-renewal and
proliferation (e.g., Bcl6b, Lhx1, Sox3, Neurog3; Figure S2A;
data not shown) are not expressed in our isolated AGSCs, sug-
gesting considerable regulatory differences in neonatal (and/or
cultured) SSCs versus AGSCs.
We then explored how chromatin might underlie the regulation
of these key self-renewal genes in AGSCs. It is interesting that
we found the transcriptional start site (TSS) regions of Nanog
and Lefty DNA methylated in AGSCs (Figures 3A and 3B) but
not in PGCs/gonocytes (E16.5), revealing DNAme acquisition
between PGCs (E16.5) and AGSCs. Remarkably, for bothNanog
and Lefty, we found the proximal enhancer DNA hypomethylated
and bivalent (note that this enhancer is intragenic for Lefty), and
we also observed the Lefty promoter highly enriched with 5hmC
(Figures 3A and 3B). Furthermore, Sox2 and Prdm14 are also
silenced in AGSCs but DNA hypomethylated and clearly marked
with promoter H3K27me3 (Figure 3A). Taken together, AGSCs
(Kit+ and Thy1+) share with PGCs/gonocytes (E16.5) a lack of
Nanog, Lefty, and Sox2 expression—but utilize different modes
of chromatin repression than PGCs (E16.5) (Figures 3A–3C)—
and differ from PGCs in their lack of Prdm14 expression.
Notably, for these four pluripotency/self-renewal genes, we
observed either promoter or enhancer chromatin/DNAme
modifications (H3K4/K27me or 5hmC) in mature sperm that
may enable their rapid transition to the active state in the embryo.
Also, we found that the binding sites for NANOG and SOX2
(and SOX2/OCT4 compound sites determined in ESCs) are
DNA methylated in AGSCs (Thy1+ and Kit+), whereas OCT4-
only sites or KLF4 sites are DNA hypomethylated (Figure 3D)
(Wang et al., 2006). Thus, the loss of SOX2 and NANOG proteins
in AGSCs is strongly reflected in the DNAme status of their
genomic binding sites. Notably, 5hmC is enriched at 50% of
NANOG-binding sites in all germ cell stages (Figure S2B), which
again may facilitate active DNAme removal in the embryo. We
next identified active and poised germline enhancers (via gener-
ating H3K4me1, H3K27ac, and H3K27me3 profiles), defined
their DNAme status, and then determined candidate transcrip-
tion factor binding sites within them. Notably, sites for particular
transcription factors were enriched at enhancers for develop-
mental genes (ELK1, ELK4, NFAT, ARID3a, and NRF1; via
regulatory sequence analysis tool, false discovery rate [FDR] <
0.01; Figure S3A, cluster 1; Table S1D). Taken together, we iden-
tified candidate enhancer regions in AGSCs and associated
transcription factor binding sites.Figure 4. Association of the Gametogenesis Program with Low-CG Co
(A–D) RNA-seq hierarchical clustering of four gene classes (as separate panels) in
the clusters representing peak expression (RNA accumulation) in each stage
spermatocytes; S’tids, spermatids.
(E) Density scatterplots and correlations of H3K4me3 and DNAme in ESCs, AGSC
H3K4me3, log2 ratio).
(F) Transcribed gene promoters, defined in (A) through (D) are partitioned into Ty
(G) Histogram depicting the number and CG frequency (Observed/expected (Ob
(H) Class average maps of the chromatin attributes of Typical and Atypical prom
See also Figures S3, S4, and S5 and Tables S4 and S6.
CNeither the Commitment of AGSCs to Gametogenesis
nor Gametogenesis Itself Involves Significant Changes
in DNAme
Next, we extend our analyses to gametogenesis, examining Kit+
AGSCs onward, and begin with DNAme. It is somewhat surpris-
ing that gametogenesis does not involve appreciable changes in
promoter DNAme: no promoters pass threshold criteria (i.e.,
>30% change in fraction methylation), nor are there persistent
changes in intergenic/enhancer DNAme linked to transcriptional
changes during gametogenesis (Figure S3B; data not shown;
note promoter chromatin-transcription relationships of the
aggregate data in Figure S3C). Notably, we find the enhancers
neighboring embryonic developmental transcription factors
(e.g., Hox, Fox, Evx, Hand, Irx, and Lxh genes, and Nanog itself)
DNA hypomethylated in all germline stages and marked with
H3K27me3, consistent with poising (Tables S3A–S3E; Fig-
ure S3D, cluster 4).
Developing Germ Cells Express a Large Repertoire of
Stage-Specific RNAs
Our transcriptome analyses involved examination of four main
gene types: (1) known protein-coding RNAs (RefSeq), (2) long
noncoding RNAs (lncRNAs) in isolation, (3) new, nonannotated
transcription units (NATs; see Experimental Procedures for char-
acterization), and (4) known piRNA clusters (Figures 4A–4D). For
each gene type, we identified gene sets with peak expression
(RNA accumulation) during a particular stage, using normaliza-
tion and clustering programs. (Note: for mature sperm, the
peak gene set represents residual RNAs, not peak transcription.)
For RefSeq genes, comparisons of Kit+ AGSCs to stages of
gametogenesis revealed 19,000 differentially expressed genes,
which were then clustered (Figure 4A) and subjected to gene
ontology (GO) analyses (Tables S4A–S4E). First, our data confirm
known/predicted stage-specific transcription of particular
RefSeq protein-coding genes during gametogenesis (Tables
S4A–S4E). Notably, for lncRNAs, we found the majority of the
known/annotated lncRNA repertoire expressed during sper-
matogenesis, with striking stage specificity and interesting GO
categories (FDR < 0.05; Figure 4B; Table S4F). Furthermore,
we observed a large number of NATs (953; fragments per kilo-
base of exon, permillionmapped reads [FPKM] > 1.4; Figure 4C),
that peak in spermatids, in agreement with recent data (Soumil-
lon et al., 2013). Of these, 227 are large intergenic and indepen-
dently transcribed units (iNATs), validated by clear independent
H3K4me3 peaks (Figures 4C and S4A). To investigate iNAT
coding potential, we applied CPAT, which calculates coding
probability (Figure S4B; Tables S4G and S4H). For piRNAs, pre-
vious work in staged postnatal mouse testes defined two phases
of piRNA production: prepachytene (primarily MILI bound) andntent and DNA-Methylated Promoters
ESCs and across germ cell stages (note: AGSCs are Kit+). For each gene class,
are examined for their promoter DNAme status directly below, (F). S’cytes,
s (Kit+), spermatocytes, and spermatids. (x axis, fraction CGmethylation; y axis
pical (lacking DNAme) or Atypical (bearing DNAme).
s/exp)) of transcribed Typical and Atypical promoters, in the Refseq class.
oters (±2.5 Kb) in the round spermatid, in the Refseq class.
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Epigenomic Maps of Germline Stem Cellspachytene (primarily MIWI bound) (Li et al., 2013). Our AGSC
piRNAs overlap nearly completely (91%) with previously desig-
nated prepachytene piRNAs (Figure 4D, cluster 1), whereas our
spermatocytes and spermatids piRNAs data sets overlap nearly
completely (95%) with previously designated pachytene piRNAs
(Figure 4D, cluster 2). Thus, our data in the adult mice aligns well
with postnatal mice regarding piRNA phases and cell origins.
Taken together, we provide deep stage-specific data sets of
protein coding, lncRNA, iNAT/intergenic units, and piRNAs for
future study.
Common Transcription of ‘‘Atypical’’ Promoters with
DNAme and H3K4me3 in the Germline
In somatic cells, DNAme is typically anticorrelated with both
transcription and H3K4me3. Surprisingly, we found DNAme
and transcription essentially uncorrelated in spermatocytes or
spermatids, and relationships of DNAme with H3K4me3 either
weak or absent (Figure 4E), suggesting major differences from
observations in ESCs or somatic cells. To characterize active
genes bearing DNAme, we examined the DNAme status of
gene promoters (lncRNAs ± 500 base pairs [bp], Refseq ± 2 kb
flanking the TSS) transcribed at each stage (Figure 4F). Remark-
ably, for RefSeq, lncRNAs, and iNATs, a high fraction (20%–
45%) of the genes with peak transcription in spermatids bear
DNAme at their TSS (Figure 4F examines the DNAme status of
the peak/red clusters within Figures 4A–4D). This fraction of
genes with DNAme was still quite high (10%–20%) in sper-
matocytes and Kit+ AGSCs, compared to the extremely low
levels in ESCs (2%) (Figure 4F). Thus, we observed two very
different classes of germline promoters: (1) the majority class,
showing ‘‘Typical’’ DNAme relationships, and (2) a very sizeable
minority with atypical relationships—active, yet bearing cor-
related DNAme and H3K4me3—termed hereinafter Atypical
promoters. In keeping, GO analyses of Atypical promoters enrich
almost exclusively categories of male gametogenesis (Tables
S5A and S5B).
For piRNAs, we found virtually all promoters driving prepachy-
tene/Kit+ AGSC piRNAs unmethylated, in keeping with their
intragenic derivation. In contrast, 31% (36/125) of unique
pachytene piRNA clusters are driven from promoters bearing
DNAme, and these methylated promoters are almost all inter-
genic (28/36) (Figure 4F). Thus, DNAme resides at the promoters
of independently transcribed/intergenic pachytene piRNA pro-
moters but not intragenic prepachytene/ Kit+ AGSC promoters.
Taken together, a marked feature of gametogenesis—especially
spermatid-specific genes and piRNAs—is the preponderance of
active Atypical promoters (20%–45% of total).
In principle, the activity of Atypical promoters might be
enabled by low CG density; mCG-dependent repression in-Figure 5. Chromatin and DNAme Relationships of Atypical Mouse Pro
(A) Representative browser snapshots of two Typical (Crem or piRNA, at left) an
matids. Note: RNAPol2 BisSeq from total germ cells. Note that, for Atypical gen
(B) RNAPol2 BisSeq (blue line) and H3K4me3 BisSeq (red line) read distribution
(C) H-clustering of miRNA from all stages of spermatogenesis, mature oocytes, cl
et al. 2010). S’Cytes, spermatocytes; S’Tids, spermatids.
(D) Injection of pooled miRNA sponges targeting paternally provided miRNAs into
0.0001.
See also Figure S6.
Cvolves methyl-CG-binding domain (MBD) proteins complexed
to histone deacetylases (HDACs). If Atypical promoters were to
uniformly display low CG content, then they might fall below a
critical MBD-HDAC threshold. It is striking that we found Atypical
promoters uniformly of low CG content, whereas Typical pro-
moters display standard CG content distributions —a relation-
ship true for each of the four gene types (Figure 4G; Figures
S5A–S5C). In contrast, ESC promoters are almost all Typical,
and very few display low CG content (Figure 4G; Figures S5A–
S5C). However, low CG content itself cannot be sufficient for
expression, as these genes are silent in ESCs and somatic cells.
To define chromatin attributes that might further distinguish
Typical from Atypical promoters, we profiled the H2A histone
variant H2A.Z (typically anticorrelated with DNAme), 5hmC
(a modification that deters the binding of most repressive MBD
proteins [MeCP2 excepted]), and both H3K27ac and H3K9ac
(present at unmethylated active genes/enhancers) (Refseq and
noncoding genes; Figure 4H; Figures S5D and S5E). Notably,
H3K27ac and H3K9ac were enriched at both Typical and Atyp-
ical promoters (Figure 4H; Figures S5D and S5E). In contrast,
H2A.Z was present at high levels only at Typical promoters (Fig-
ure 4H), as well as at low levels at bivalent developmental genes
(data not shown). Remarkably, in round spermatids, 5hmC was
selectively present (FDR < 20) at55%of active Atypical RefSeq
genes and 70% of active Atypical piRNA promoters, but not at
Typical promoters (i.e., Crem; Figure 4H). Remarkably, addi-
tional chromatin immunoprecipitation sequencing (ChIP-seq)
profiling of RNA polymerase II (RNAPol2) revealed more RNA-
Pol2 at Atypical promoters than Typical promoters (Figure 4H;
Figures S5D and S5E), with examples provided in Figures 5
and S6A. Thus, a large fraction of the gametogenesis and pachy-
tene piRNA program involves transcription from low CG content
promoters that bear DNAme, H3K4me3, 5hmC, and high acety-
lation levels but—unlikemost active genes in somatic cells—lack
H2A.Z.
ChIP-BisSeq Verifies High H3K4me3 and RNAPol2
on DNA-Methylated Promoters
To directly examine coincidence of DNAme, H3K4me3, and
RNAPol2, we performed ChIP bisulfite sequencing (ChIP-
BisSeq) using multiplex sequencing of candidate TSS regions
of multiple genes (both Typical and Atypical) in round sperma-
tids. It is interesting that ChIP-BisSeq with H3K4me3 revealed
DNAme at the TSS of Atypical, but not Typical, promoters (Fig-
ure 5A). To determine whether these regions are truly transcribed
in the presence of DNAme—or instead transcribed while DNA is
demethylated, and then subsequently remethylated—we per-
formed ChIP-BisSeq with RNAPol2 from total germ cells and
again observed DNAme underlying only Atypical promotersmoters and Small Noncoding RNA Repertoire
d two Atypical (protamine or piRNA cluster, at right) promoters in round sper-
es, the H2A.Z track was omitted, as it lacked peaks.
of fraction CG methylation.
eavage, and blastocyst (oocyte and embryo small RNAs obtained from Ohnishi
pronuclear mouse embryos reduces blastocyst frequency. *p = 0.0008; **p =
ell Stem Cell 15, 239–253, August 7, 2014 ª2014 Elsevier Inc. 247
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Epigenomic Maps of Germline Stem Cells(Figure 5A). Furthermore, we examined the distribution of
sequencing reads with respect to their DNAme status; here,
the vast majority of the reads (>95%) bore mCG at the vast
majority of the CGs within that read (Figure 5B; Figure S6B). In
contrast, for Typical genes (e.g.,Crem or certain piRNA clusters),
the vast majority of the reads were mostly hypomethylated CGs
(<0.2 mCG at >95% of reads; Figure 5B), demonstrating that
Atypical genes are transcribed with a methylated TSS in
spermatids.
Coincidence of H3K4me3, RNAPol2, and DNAme was also
observed at both lncRNAs and piRNA clusters, which also
show stage-specific expression and stage-specific occupancy
by RNAPol2. Here, ChIP-BisSeq again revealed DNAme under-
lying H3K4me3 and RNAPol2 at the analyzed Atypical piRNA
promoters (Figure 5A; right panel) but not those with Typical pro-
moters (Figure 5A, left panel).
Sperm-Specific miRNAs Are Associated with EMT,
Proliferation, and Pluripotency
We profiled mouse miRNAs from AGSCs and gametogenesis
stages, combined with previous data from oocyte, morula,
ICM, and blastocysts (Ohnishi et al., 2010), yielding 512 total
miRNAs (log2 FPKM > 1.5) (Figure 5C; Table S4I). Clustering
analyses revealed three major types: (1) miRNAs present in
male germ cells including mature sperm (expressed at varying
levels) but absent in oocytes (termed miSPHigh; 260 total), (2)
miRNAs expressed in Kit+ AGSCs and downregulated in
differentiated germ cells and absent in early embryos (termed
miAGSCHigh; 15 total; unknown function), and (3) miRNAs pro-
vided both maternally and paternally and maintained during
embryogenesis (150 total).
Regarding the miSPHigh type, our results confirm miR-34c as
the most abundant miRNA in mature sperm (log2 FPKM = 22)
(Liu et al., 2012) and show further its high expression in Kit+
AGSCs and depletion in the oocyte. It is interesting that miR-
34c affects the first cleavage division (Liu et al., 2012). Notably,
when considering the top 20 (log FPKM> 13)miSPHigh members,
most have roles in cancer, epithelial-to-mesenchymal transition
(EMT), cell proliferation, or translational repression of the ESC
pluripotency network (Sox2, Klf4, and Oct4 mRNAs): miR-
10a/b, miR-23a, miR-196a/b, miR-24, miR-451, miR-134, miR-
380-5p, miR-9, miR-145, miR-134, miR-296, and miR-470. To
explore possible functional roles for miRNAs retained in mature
sperm in embryos, we selected eight miRNAs (from miSPHigh)
known to target MAPK, ERB, or TGFb signaling pathways.
Here, we injected into the male pronucleus an equimolar con-
centration of a pool of eight miRNA sponges, which resulted in
a significant reduction in blastulation rate (65% versus 35%),
as compared to the negative control (scrambled sponge pool;
Figure 5D; p < 0.05). Taken together, we have defined the miR-
NAs of Kit+ AGSCs and gametogenic stages and provide initial
preliminary data that paternally provided miRNAs may affect
embryogenesis.
Conservation in Human Sperm of Enhancer Poising,
Atypical Promoters, and Small RNAs
We then tested for conservation of key concepts in mature
human sperm by profiling DNAme, chromatin, and multiple
RNA species (Figure 6A). Enhancer profiling revealed poised248 Cell Stem Cell 15, 239–253, August 7, 2014 ª2014 Elsevier Inc.enhancers (H3K4me1+H3K27me3, but lacking H3.3); as in the
mouse, these localize (by GO analysis) near developmental
factors of importance in the embryo (Figure S7A; Tables S3F
and S3G). Regarding chromatin poising of pluripotency network
factors, clear human-mouse similarity is observed at SOX2 and
PRDM14 (which bear bivalent promoters) and also LEFTY (with
a 5hmC-enriched and a poised internal enhancer). However,
human OCT4 and NANOG promoters are DNA methylated and
lack a clear poised enhancer (Figure S7B) in humans.
Notably, regions with H3K4me3 slightly correlated with DNA
methylation (Figure 6B), whereas H3K27me3 strongly anti-
correlated (p < 0.01). To find and examine Atypical human pro-
moters, we extended the MNase ChIP-BisSeq protocol with
H3K4me3 to a genomewide format (Figure 6C; note that mature
human sperm is transcriptionally silent but retains H3K4me3 at
previously transcribed promoters). Notably, read distributions
(Figure 6C) reveal two types of loci: (1) those bearing high
H3K4me3 and DNAme (Atypical), which map almost solely to
low CG-content promoters (Figure 6D), and (2) loci with high
H3K4me3 lacking DNAme (Typical), which map largely to inter-
mediate-high CG-content promoters (Figure 6D). Promoters of
genes with high H3K4me3 and DNAme are genes highly tran-
scribed during gametogenesis—including protamine genes,
transition protein genes, and 50% of piRNA clusters (for piRNAs,
promoters were defined by coincident RNA-seq read starts and
H3K4me3 peaks) (Figure 6E). In contrast, Typical genes (e.g.,
Crem) lack DNAme underlying their promoter H3K4me3 peaks
(Figure 6E). Notably, we observed a 45% overlap between
conserved Atypical promoters identified in the mouse and those
in humans (Tables S5C and S5D). Taken together, the data are
consistent with Atypical promoter utilization as a conserved
property of mouse and human gametogenesis.
RNA Profiles in Human Mature Sperm
Regarding RNAs in mature sperm, we performed RNA-seq on
two donors (D1 and D2), deriving separately long RNA (>200
bases) and small RNA (<200 bases). As data sets from D1 and
D2 were highly correlated (r = 0.835, p < 0.0001), they were
combined (>200 million reads). Long RNA was of low
abundance, and those detected were those RNAs most highly
transcribed during spermatogenesis or spermiogenesis and
are therefore likely residual (Table S6A). For miRNAs, we found
a large number of mature miRNAs (325; FPKM > 1) shared
between the two donors (80% overlap), greatly increasing pre-
vious estimates (35 miRNAs), with complete agreement/overlap
(Figure S7B; Tables S6B and S6C). It is interesting that the vast
majority (85%) of miRNAs common between D1 and D2 in
mature sperm overlapped with those in ES cells (H1 cells; Fig-
ure S7C; Table S6C). Furthermore, of the top 30 miSPHigh
members in mice, 25 are within the top 100 miRNAs in human
sperm. Furthermore, for those miRNAs with shared mouse/
human nomenclature (280), we observed a 59% overlap (192/
280) of miRNAs found in mouse and human mature sperm (Fig-
ure S7D; Table S6D). Finally, we reveal a large number (9,511;
FPKM > 1) of piRNAs shared between D1 and D2 data sets
(79% overlap; Figure S7E; Table S6E), although with almost no
overlap with previous data sets (Krawetz et al., 2011). Thus, we
greatly increase the known repertoire of retained miRNAs and
piRNAs in sperm.
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Figure 6. Co-Occupancy of H3K4me3 and DNAme at Low-CG Content Regions in Mature Human Sperm
(A) Graphical summary of human sperm data sets generated (gray boxes).
(B) Density scatterplots and correlations of H3K4me3 and DNAmethylation in ESC (top) and mature sperm (bottom). (x axis, fraction CGmethylation, range, 0–1;
y axis, H3K4me3 log2 ratio).
(C) The distribution of fraction CGmethylation for the reads from the H3K4me3 BisSeq data set. The reads were partitioned into DNA hypomethylated (blue bars)
or hypermethylated (red bars) for use in (D).
(D) CG frequency (Obs/Exp, observed/expected) of the DNA hypomethylated or hypermethylated BisSeq reads from (C).
(E) Browser snapshots of representative Typical and Atypical promoters in human sperm. Depicted are DNAme (D1+D2, fraction CG methylation), D1+D2
H3K4me3 ChIP-seq (Qval FDR), and H3K4me3-BisSeq (fraction CG methylation). Arrows in the piRNA clusters are used to depict the predicted TSS of the
transcribed cluster, based on H3K4me3 peaks.
See also Figures S6 and S7.
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Our work uses extensive genomic profiling to better understand
AGSC self-renewal, commitment to gametogenesis, game-
togenesis stages, and germline genome pluripotency. Fore-
most, we aimed to understand how chromatin packaging and
transcription networks help regulate these processes and
poise/prepare genes for each subsequent stage. Our work
provides new insights into AGSC biology and reveals
several remarkable features of chromatin utilization during
gametogenesis.CDistinctive Signaling and Transcription Pathway
Signatures Define Thy1+ versus Kit+ AGSCs
First, regarding self renewal, our transcriptional profiling reveals
clear differences between the Thy1+ versus Kit+ AGSCs,
including the selective presence or absence of particular
signaling factors, tumor suppressors, proto-oncogenes, and
transcription factors. It is interesting that only Thy1+ cells ex-
press Csf1r, Il10r, and Tnfr, providing receptors for a set of cyto-
kines secreted by cells (macrophages, monocytes, or dendritic
cells) residing in the interstitium adjacent to the wall of the sem-
iniferous tubule but absent in Kit+ cells (which migrate centrally).ell Stem Cell 15, 239–253, August 7, 2014 ª2014 Elsevier Inc. 249
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Epigenomic Maps of Germline Stem CellsFurthermore, we reveal an interesting example of cytokine/
receptor asymmetry (Pdgf in Thy1+, Pdgfra in Kit+) that raises
the possibility of signaling between different AGSC cell types.
RAS signaling promotes AGSC/SSC proliferation in vitro, and
we find H-Ras highly expressed in both Thy1+ and Kit+ AGSCs
in vivo. Notably, Harvey rat sarcoma viral oncogene homolog
(H-RAS) pathway activation elicits SSC self-renewal through
transcriptional regulation of the cyclins Ccne1 or Ccnd2. It is
interesting that we found Ccne1 expressed only in Thy1+ cells
and Ccnd2 expressed only in Kit+ cells. Thus, RAS signaling
appears involved in both Thy1+ and Kit+ AGSCs, but certain
regulators and targets are different. Furthermore, transplantation
of cultured SSCs bearing constitutively active H-RAS into the
testis gives rise to germ cell tumors, emphasizing the importance
of RAS regulation in vivo (Lei et al., 2011). Notably, we find Dab2
(a known modulator of the RAS pathway in other cell types)
expression in Thy1+ cells, which raises the question of whether
DAB2 may be modulating RAS signaling and preventing uncon-
trolled proliferation of AGSC. In D. melanogaster, SSC self-
renewal is also regulated by NFkB, and only in Thy1+ cell do
we observe high Aim2, which controls cell proliferation by sup-
pressing NFkB. Our data sets also verify the known involvement
of retinoic acid in the Thy1+-to-Kit+ transition and here reveal two
key promoters (Aldh2 and Stra8) as bivalent in Thy1+ cells but
only H3K4me3 (and transcribed) in Kit+ AGSCs. Notably, Aldh2
and Stra8 provide rare examples in our data sets of a bivalent
gene losing H3K27me3 and then becoming active. Beyond
these rare exceptions, germline developmental transitions
almost never involve gene activation by resolving bivalency
(removing H3K27me3), whereas H3K27me3 removal commonly
accompanies gene activation during ESC differentiation. Overall,
our results reveal new signaling pathways, factors, and pro-
cesses for study in AGSCs and their niche and may inform their
proper culturing in vitro.250 Cell Stem Cell 15, 239–253, August 7, 2014 ª2014 Elsevier Inc.AGSCs Poise the Factors Needed for ESC Self-Renewal
and Embryo Development
We found the expression of pluripotency factors in AGSCs
more similar to PGCs than ESCs. For example, AGSCs and
PGCs (E16.5) lack expression of Nanog, Sox2, and Lefty
(and, additionally, Prdm14 in AGSCs) but may utilize different
repression mechanisms; Nanog and Lefty promoters have high
DNAme in AGSCs but not in E16.5 PGCs (Seisenberger et al.,
2012) (Figure 7). Remarkably, in mature sperm (human and
mouse), each of these genes possesses (or maintains from
AGSCs) bivalency and/or 5hmC at their TSS or proximal
enhancer, providing alternative modes of poising for their rapid
activation in the embryo. Notably, these candidate poising
features appear conserved in human sperm at SOX2,
PRDM14, and LEFTY but not atOCT4 andNANOG; their methyl-
ation in sperm necessitates prompt demethylation in the em-
bryo, a process that might be facilitated by the slightly later
maternal-zygotic transition in humans than mice.
AGSCs appear to blend the use of factors present in PGCs
with those typically associated with adult stem cells. For
example, AGSCs resemble other adult stem cells in silencing
Nanog and Lefty yet expressing Myc, Aldh2, Lrig1, Olfm1, and
Bmi1 (Sangiorgi and Capecchi, 2008). Also, AGSCs share with
neural stem cells the GFRA1/GDNF signaling axis (a pathway
critical for AGSC self-renewal) and also Foxo3 expression (Lei
et al., 2011; Ro et al., 2013). Furthermore, prior genetic work
has implicated PLZF (Zinc Finger and BTB Domain Containing
16) and ETV5 (Ets Variant 5) in AGSC self-renewal (Costoya
et al., 2004; Dovere et al., 2013; Hobbs et al., 2010), results
supported here by high transcript levels in AGSCs. Thus, a
unique blend of these factors help AGSCs to poise the ESC-
like pluripotency program for future utilization in the embryo
while simultaneously enforcing a unipotent developmental pro-
gram (gametogenesis) within the testicular niche. Notably,
Cell Stem Cell
Epigenomic Maps of Germline Stem Cellscultured AGSCs/SSCs re-expressNanog and Sox2 (Meyer et al.,
2010), supporting the notion that signaling factors within the
niche may suppress pluripotency by reinforcing germ cell
identity and alignment to gametogenesis, which may help
prevent germ cell tumor formation; indeed, the ‘‘embedding’’
of pluripotency within AGSC chromatin may underlie their ability
to form teratomas that contain tissues derived from all three
germ layers.
Remarkably, both Thy1+ and Kit+ AGSCs display bivalency
(and transcriptional silencing) at promoters for embryonic devel-
opmental transcription factors and also possess poised
upstream enhancers—properties that are maintained through
gametogenesis stages. Coupled with previous studies in mature
sperm, spermatocytes, and PGCs (Hammoud et al., 2009; Lesch
et al., 2013; Ng et al., 2013), bivalency/poising of the promoters
and enhancers of embryonic transcription factors and key
signaling factors may be a consistent feature of the germline
cycle to ensure their transfer to the embryo in a transcriptionally
competent state while also maintaining their silencing in the
germline (via H3K27me3). Here, a key unresolved issue is the
factor(s) targeting H3K27me3 deposition to embryonic transcrip-
tion factors in AGSCs; our work suggests OCT4 and MYC as
leading candidates.
Gametogenesis Involves the Broad Use of Atypical DNA
Methylated Promoters
Our profiling of gametogenesis (from Kit+ AGSCs to mature
sperm) revealed five unexpected features (Figure 7). First, we
found no significant changes in promoter or enhancer DNAme
accompanying gametogenesis. Second, a remarkable fraction
(20%–45%) of RefSeq promoters transcribed in Kit+, sper-
matocytes, and especially spermatids were Atypical, bearing
DNA methylation, RNAPol2, and H3K4me3. Notable earlier
studies observed a correlation between regional DNAme and
expression, either at the protamine genes in spermatids (Choi
et al., 1997) or at a small number of low-CG content genes in
fibroblasts (Weber et al., 2007). However, these studies did not
address whether interconversion occurs between DNA methyl-
ated and unmethylated states, with transcription occurring while
unmethylated. Here, we provide direct evidence through ChIP-
BisSeq approaches in mouse spermatids and in mature human
sperm. Third, we reveal a marked fraction (31%) of pachytene
piRNA promoters as Atypical and establish prepachytene
piRNAs as AGSC derived in adults. Fourth, profiles of miRNAs
in human and mouse mature sperm are remarkably similar,
except for key miRNAs previously linked to pluripotency. It is
interesting that >70% of the miRNAs retained in mature sperm
are expressed in ESCs. In humans, our small RNA data sets
greatly expand the known repertoire of retained human miRNAs
and piRNAs. Fifth, we revealed conserved properties of Atypical
promoters that may (together) enable their transcription: (1) low
CG content, (2) a portion marked with 5hmC, and (3) the known
H3K9me-to-acetyl switch, involving H3K9 demethylation by
KDM3A (Okada et al., 2010) followed by high H3K9ac and
H3K27ac acquisition in spermatids. The first two attributes likely
function together to attenuate MBD protein binding and, there-
fore, MBD-HDAC complex repression, whereas the H3K9me/
ac switch likely involves the loss of repressive H3K9me at or after
the pachytene stage in spermatocytes.CRecent work profiled stage-specific intergenic transcription
during gametogenesis (verified in our data sets), which was
previously attributed tomarkedly lower DNAme levels (Soumillon
et al., 2013). Instead, we found DNAme levels slightly higher in
spermatocytes and spermatids than in AGSCs, ESCs, or so-
matic tissues (Table S1F). Alternatively, we suggest that the
low CG content (and 5hmC) sensitizes Atypical promoters to ac-
tivity when MBD-HDAC chromatin repression mechanisms are
attenuated. Their activity in the germline (and not in the soma)
must further rely on germline- and stage-specific transcription
factors (e.g., CREM isoforms) and chromatin factors (e.g.,
H3K9me/ac transitions) to generate stage-specific transcrip-
tional waves during gametogenesis without changes in DNAme.
It is remarkable that many gametogenesis-specific genes are
intronless or contain a single intron, thus having likely evolved
via retrotransposition (i.e., retrogenes) (Dorus et al., 2006; Vibra-
novski et al., 2009). To enable contribution of a retrogene to
fitness, the germline must evolve mechanisms to express these
new randomly inserted retrogenes at low/moderate levels and
to provide an evolutionary route to enable higher expression if
the new retrogene provides a fitness benefit to the current devel-
opmental program (spermiogenesis) or individual. Here, we
suggest that an attenuation of chromatin repressionby themech-
anisms discussed earlier may enable both initial low-level retro-
gene expression, as well as a route to positive selection for
increased expression, involving progressive CG-content loss,
acquisition of transcription factor binding sites (e.g., CREM-
tau), and acquired TET protein recruitment. We suggest that
positive selection may have enabled a high fraction of the game-
togenesis program to acquire and utilize anAtypical architecture.
Finally, an important conceptual issue addressed here is
whether and how the genome maintains a competent pluri-
potent/stem cell state while executing in parallel a complex uni-
potent developmental pathway (gametogenesis). Here, only the
gametogenesis program utilizes Atypical chromatin-transcrip-
tion relationships (involving transcription from DNA-methylated
promoters with 5hmC, with no changes in DNAme) and may
utilize specialized basal transcription factors (e.g., TAF7L) that
may allow gametogenesis to occur without compromising the
chromatin poising of the pluripotency program. We speculate
that this chromatin/DNAme poising of self-renewal and develop-
mental factors in the spermmay greatly enable the totipotency or
pluripotency achieved by the zygote and ICM, respectively. Our
work provides insight into how chromatin and pluripotency
factors help maintain and re-establish pluripotency within the
germline while also orchestrating the largest chromatin change
in developmental biology.EXPERIMENTAL PROCEDURES
Mouse Husbandry and Germ Cell Isolation
C57Bl/6 mice were maintained on a normal 12 hr light/dark cycle. Spermato-
cytes, spermatids, and mature sperm were collected from 8- to 12-week-old
mice (see Supplemental Experimental Procedures). All experiments were
done under an approved Institutional Animal Care and Use Committee
protocol.
Isolating AGSCs
Isolation of the Thy1+ or c-kit+ stem cell fraction was carried out with a mag-
netic cell sorting separator (Miltenyi Biotec) using anti-CD117 antibody orell Stem Cell 15, 239–253, August 7, 2014 ª2014 Elsevier Inc. 251
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Epigenomic Maps of Germline Stem Cellsanti-CD90.2 (Thy1) (Miltenyi Biotec) (see Supplemental Experimental Proce-
dures). Quantitative PCR was used to confirm stem cell purity.
Isolating Spermatocytes, Spermatids, and Mature Sperm
Spermatocytes and spermatids were isolated by centrifugal elutriation (see
Supplemental Experimental Procedures). Mature sperm was collected from
the vas deferens, filtered in a 40 mm strainer, and pretreated with a somatic
cell lysis buffer (0.1% SDS, 0.5% Triton) to remove any contaminating somatic
cells. Washed sperm was used for either DNA or RNA extraction.
FACS Analysis
Purified cells were analyzed by flow cytometry using FACSCalibur (BD Biosci-
ences) to assess DNA content. Live cells were identified and gated by exclu-
sion of propidium iodide. Fluorescence-activated cell sorting (FACS) data
were analyzed using the FlowJo software.
Mouse ChIP
ChIP was performed as described elsewhere (see Supplemental Experimental
Procedures). Libraries were prepared using standard Illumina pipeline and
sequenced using a 50-bp single-end format on an Illimina HiSeq 2000.
Antibodies used were as follows: anti-H3K27ac (Active Motif #39135),
H3K4me1 (Abcam #8895), H3K4me3 (Active Motif #39159), H3K27me3
(Upstate #07-449), H3K9ac (Upstate #06-942), RNA Pol2 (Active Motif
#61085),and H2A.Z (Abcam ab41744).
Human Biological Samples
The two sperm donor samples were obtained from two men of known fertility
attending the University of Utah Andrology Laboratory, who consented for
research. Samples were collected after 2–5 days abstinence and subjected
to a density gradient (to purify viable, motile, and mature sperm). The purified
sperm was either used for RNA/DNA extraction or subjected to MNase digest
and ChIP (see Supplemental Experimental Procedures).
Human Sperm ChIP
ChIP was performed as previously described by Hammoud et al. (2009).
Antibodies were as follows: anti-H3K27ac (Active Motif # 39135), H3K4me1
(Abcam #8895), and Anti-H3F3B (H3.3 abnova).
Mouse and Human Sperm RNA Extraction and Library Preparation
RNA extractions were performed following Ambion standard protocol (Ambion
Life Technologies). Total RNA was DNase treated (Ambion #AM1907). Small
and long (Ribozero-treated) directional RNA-seq libraries were constructed
according to Illumina’s protocol and sequenced using a 50 bp single-end
format on an Illumina HiSeq 2000.
Mouse and Human BisSeq and Library Preparation
A total of 50 ng–1 mg of extracted genomic DNA was sheared (COVARIS)
and spiked with 1% unmethylated lambda (Promega), and the library was
constructed using the TruSeq DNA sample prep kit (Illumina Inc). Bisulfite
treatment was conducted using the Epitect bisulfite kit (see Supplemental
Experimental Procedures) and sequenced using a 101-bp paired-end format
on an Illimina HiSeq 2000.
Genomics and Data Access
Detailed description of the genomics methods and bioinformatics analyses
are provided in the Supplemental Experimental Procedures. All data described
in this article may be downloaded from Gene Expression Omnibus under
the accession project ID GSE49624. This includes raw fastq files and
processed files for BisSeq, ChIP-seq, RNA-seq, and 5hmC enrichment
experiments.
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